Short answer
Pediatrix Medical Group, Inc. (MD) filed its Q2 2026 10-Q quarterly report on Aug 4, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $488M (up 4.0% year over year) with net income of $40M.
Q2 2026 key financials · XBRL
- Revenue
- $488M
- +4.0% YoY · +2.4% QoQ
- Net income
- $40M
- +1.5% YoY · +34.7% QoQ
- Operating margin
- 11.7%
- EPS (diluted)
- $0.49
- +6.5% YoY · +36.1% QoQ
Source: XBRL data from the Pediatrix Medical Group, Inc. (MD) Q2 2026 10-Q on SEC EDGAR. USD.
Pediatrix Medical Group, Inc. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No material changes to risk factors previously disclosed in the 2025 Form 10-K
- Share-repurchase exposure: $145.5 million repurchased under the August 18, 2025 program as of June 30, 2026
- Regulatory cost: 1% excise tax on share repurchases under the Inflation Reduction Act of 2022
- Market risk: future repurchases dependent on general economic and market conditions
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Pediatrix Medical Group, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.